Clinical Trials Directory

Trials / Completed

CompletedNCT02030210

CP4ACS - Delphi Study to Determine Appropriateness of STEMI Quality Indicators in Belgium

Quality of Care for STEMI - Patients. a Research to Determine Appropriateness of STEMI Quality Indicators in Belgium, a RAND/UCLA Modified Delphi Study

Status
Completed
Phase
Study type
Observational
Enrollment
32 (actual)
Sponsor
European Pathway Association · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Accepted

Summary

RAND/UCLA modified Delphi study on quality indicators for STEMI to determine the appropriateness of quality indicators retrieved from literature and guideline review. We aim to engage 20 cardiologists and 20 nurses with relevant experience in the care for STEMI patients.

Conditions

Timeline

Start date
2013-07-01
Primary completion
2013-11-01
Completion
2013-11-01
First posted
2014-01-08
Last updated
2022-04-04

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT02030210. Inclusion in this directory is not an endorsement.

CP4ACS - Delphi Study to Determine Appropriateness of STEMI Quality Indicators in Belgium (NCT02030210) · Clinical Trials Directory